Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fortunato Morabito

Showing results (11-20 of 302) with videos related to

Pageof 31
Sort By:
Expert Opinion on Biological Therapy|May 23, 2013
Perspectives in the treatment of multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Expert Opinion on Biological Therapy|March 27, 2012
Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?Massimo Martino, Roberta Fedele, Elisabetta Massara, et al.
Molecular Medicine (Cambridge, Mass.)|March 24, 2007
The CD38 ectoenzyme family: advances in basic science and clinical practiceFortunato Morabito, Rajendra N Damle, Silvia Deaglio, et al.
Journal of Immunology Research|January 21, 2016
Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated ReviewRoberta Fedele, Massimo Martino, Anna Grazia Recchia, et al.
Expert Opinion on Pharmacotherapy|May 14, 2014
Role of new drugs incorporated into consolidation and maintenance therapy in transplant-eligible multiple myeloma patientsMassimo Gentile, Ernesto Vigna, Anna G Recchia, et al.
Expert Review of Hematology|September 2, 2014
Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelinesStefano Molica, Diana Giannarelli, Rosanna Mirabelli, et al.
Expert Review of Hematology|June 21, 2013
Oxidative stress in oncohematologic diseases: an updateSelene Imbesi, Caterina Musolino, Alessandro Allegra, et al.
Expert Opinion on Investigational Drugs|April 8, 2011
How to treat patients with relapsed/refractory multiple myeloma: evidence-based information and opinionsMassimo Offidani, Laura Corvatta, Fortunato Morabito, et al.
Blood|May 24, 2003
CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cellsSilvia Deaglio, Andrea Capobianco, Luciana Bergui, et al.
International Journal of Hematology|July 28, 2014
A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL)Stefano Molica, Diana Giannarelli, Luciano Levato, et al.
Pageof 31

Showing results (11-20 of 302) with videos related to

Sort By:
Pageof 31
Expert Opinion on Biological Therapy|May 23, 2013
Perspectives in the treatment of multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Expert Opinion on Biological Therapy|March 27, 2012
Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?Massimo Martino, Roberta Fedele, Elisabetta Massara, et al.
Molecular Medicine (Cambridge, Mass.)|March 24, 2007
The CD38 ectoenzyme family: advances in basic science and clinical practiceFortunato Morabito, Rajendra N Damle, Silvia Deaglio, et al.
Journal of Immunology Research|January 21, 2016
Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated ReviewRoberta Fedele, Massimo Martino, Anna Grazia Recchia, et al.
Expert Opinion on Pharmacotherapy|May 14, 2014
Role of new drugs incorporated into consolidation and maintenance therapy in transplant-eligible multiple myeloma patientsMassimo Gentile, Ernesto Vigna, Anna G Recchia, et al.
Expert Review of Hematology|September 2, 2014
Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelinesStefano Molica, Diana Giannarelli, Rosanna Mirabelli, et al.
Expert Review of Hematology|June 21, 2013
Oxidative stress in oncohematologic diseases: an updateSelene Imbesi, Caterina Musolino, Alessandro Allegra, et al.
Expert Opinion on Investigational Drugs|April 8, 2011
How to treat patients with relapsed/refractory multiple myeloma: evidence-based information and opinionsMassimo Offidani, Laura Corvatta, Fortunato Morabito, et al.
Blood|May 24, 2003
CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cellsSilvia Deaglio, Andrea Capobianco, Luciana Bergui, et al.
International Journal of Hematology|July 28, 2014
A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL)Stefano Molica, Diana Giannarelli, Luciano Levato, et al.
Pageof 31